Literature DB >> 21575953

A 5-year prospective study of vaginal pessary use for pelvic organ prolapse.

Farah Lone1, Ranee Thakar, Abdul H Sultan, George Karamalis.   

Abstract

OBJECTIVE: To evaluate prospectively the use of vaginal pessaries for pelvic organ prolapse (POP) and to identify complications and reasons for discontinuing pessary use over a 5-year period.
METHODS: A prospective observational study was conducted among all women with POP referred to the urogynecology clinic of a UK hospital between June 2002 and June 2005 who opted to use a vaginal pessary. Patients were followed-up for 5 years.
RESULTS: Of the 246 women who chose to use a vaginal pessary, 187 successfully retained the pessary 4 weeks after insertion. Over a 5-year period, 36 (19.3%) of the 187 women were lost to follow-up. Of the 151 women included in the analysis, 21 (13.9%) discontinued use at some point after 4 weeks, whereas 130 (86.1%) used the pessary successfully over 5 years. Overall, 12.1% of the women experienced minor complications (6.9% pain or discomfort, 3.2% excoriation or bleeding, and 2.0% disimpaction or constipation). Most failures (73.8%) occurred within 4 weeks of pessary insertion. After cessation of pessary use, 70 (28.5%) of the 246 women chose surgery and 10 (4.1%) chose no further treatment.
CONCLUSION: If treatment of POP with a vaginal pessary is successful at 4 weeks, most women will continue to use the pessary over 5 years without a concomitant increase in complications.
Copyright © 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21575953     DOI: 10.1016/j.ijgo.2011.02.006

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  27 in total

Review 1.  Functional Disorders: Rectocele.

Authors:  W Conan Mustain
Journal:  Clin Colon Rectal Surg       Date:  2017-02

2.  Diagnosis and Therapy of Female Pelvic Organ Prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015/006, April 2016).

Authors:  K Baeßler; T Aigmüller; S Albrich; C Anthuber; D Finas; T Fink; C Fünfgeld; B Gabriel; U Henscher; F H Hetzer; M Hübner; B Junginger; K Jundt; S Kropshofer; A Kuhn; L Logé; G Nauman; U Peschers; T Pfiffer; O Schwandner; A Strauss; R Tunn; V Viereck
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

3.  Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.

Authors:  Benjamin C Shayo; Gileard G Masenga; Vibeke Rasch
Journal:  Int Urogynecol J       Date:  2018-08-18       Impact factor: 2.894

Review 4.  Pessaries (mechanical devices) for pelvic organ prolapse in women.

Authors:  Carol Bugge; Elisabeth J Adams; Deepa Gopinath; Fiona Reid
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

5.  Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.

Authors:  Sophie Ramsay; Le Mai Tu; Cara Tannenbaum
Journal:  Int Urogynecol J       Date:  2016-02-12       Impact factor: 2.894

6.  One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires.

Authors:  Farah Lone; Ranee Thakar; Abdul H Sultan
Journal:  Int Urogynecol J       Date:  2015-04-11       Impact factor: 2.894

7.  Laparoscopic sacrohysteropexy versus vaginal hysterectomy for uterovaginal prolapse using validated questionnaires: 2-year prospective study.

Authors:  Farah Lone; Tamara Curnow; Sarah Anne Thomas
Journal:  Int Urogynecol J       Date:  2017-07-07       Impact factor: 2.894

8.  Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.

Authors:  Birte Wolff; Kathryn Williams; Allen Winkler; Lawrence Lind; Dara Shalom
Journal:  Int Urogynecol J       Date:  2016-12-10       Impact factor: 2.894

9.  Defecatory dysfunction and other clinical variables are predictors of pessary discontinuation.

Authors:  Erin G Dengler; Louisa A Mounsey; Francesca Gines; Manahil Agha; Terri Long; Elizabeth J Geller
Journal:  Int Urogynecol J       Date:  2018-10-20       Impact factor: 2.894

10.  The cube pessary: an underestimated treatment option for pelvic organ prolapse? Subjective 1-year outcomes.

Authors:  Zoltan Nemeth; Sándor Nagy; Johannes Ott
Journal:  Int Urogynecol J       Date:  2013-04-12       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.